{"id":"W3166268850","doi":"10.1200/jco.2021.39.15_suppl.e16561","title":"Real-world treatment patterns and overall survival in previously treated advanced renal cell carcinoma patients receiving nivolumab in the UK.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Nivolumab; Medicine; Pazopanib; Axitinib; Sunitinib; Renal cell carcinoma; Cabozantinib; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Surgery; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007318754,0.00024167,0.0004544796,0.001162795,0.0003388447,0.001028379,0.0004949591,0.0005612462,0.001718255],"category_scores_gemma":[0.003606919,0.0003353746,0.000593289,0.002161086,0.0003846656,0.0007084595,0.001004326,0.0005007521,0.000404548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001217091,"about_ca_system_score_gemma":0.0005559265,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01859432,"about_ca_topic_score_gemma":0.02532821,"domain_scores_codex":[0.9986805,0.0003107122,0.0002467001,0.000342923,0.0002079823,0.0002111248],"domain_scores_gemma":[0.9954916,0.0004210152,0.003301715,0.0001751292,0.0002482852,0.0003623369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001553483,0.00001172267,0.9985317,0.00002216392,0.00004920636,0.00009492048,0.00011362,0.00003877245,0.00007101924,0.000008348276,0.0001518188,0.0007513717],"study_design_scores_gemma":[0.00001017484,0.00006474338,0.9989549,0.00001922789,0.0000208635,0.0003226166,0.0001618059,0.0001225646,0.00003195967,0.000008475395,0.0002766345,0.000006037811],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974679,0.0006136444,0.00004130733,0.00006105159,0.000006115039,0.00001511906,0.001527339,0.000002578421,0.0002650926],"genre_scores_gemma":[0.9987193,0.0001628503,0.00003774502,0.00003862799,0.000006523525,0.0000130671,0.0009074374,0.00000239719,0.0001120478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01859432,"threshold_uncertainty_score":0.03697217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0763595982025691,"score_gpt":0.3890791354664847,"score_spread":0.3127195372639156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}